KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 156 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,473,000 | -1.4% | 86,326 | -1.0% | 0.01% | +12.5% |
| Q2 2015 | $6,565,000 | +127.6% | 87,171 | +51.6% | 0.01% | +100.0% |
| Q1 2015 | $2,884,000 | +65.9% | 57,517 | +14.7% | 0.00% | +100.0% |
| Q4 2014 | $1,738,000 | +4.8% | 50,125 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $1,658,000 | -13.9% | 50,609 | +0.9% | 0.00% | -33.3% |
| Q2 2014 | $1,925,000 | +48.0% | 50,175 | +53.3% | 0.00% | +50.0% |
| Q1 2014 | $1,301,000 | +7.3% | 32,720 | +0.8% | 0.00% | 0.0% |
| Q4 2013 | $1,213,000 | -7.5% | 32,470 | +12.9% | 0.00% | 0.0% |
| Q3 2013 | $1,311,000 | +82.3% | 28,754 | +8.2% | 0.00% | +100.0% |
| Q2 2013 | $719,000 | – | 26,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |